I. V. Additive Review Addition of Drugs to Intravenous Fluids

Abstract

Get full access to this article

View all access options for this article.

References

Anderson

R. W.

Latiolais

C. J.

(1970), “Physio-chemical Incompatibilities of Parenteral Admixture of Ara-mine and Solu-Cortef,” Am. J. Hosp. Pharm. 27: 540.

Bair

J. N.

Carew

D. P.

(1965), “Therapeutic Availability of Antibiotics in Parenteral Solutions,” Bull. Parent. Drug Assoc. 19: 153.

Barker

K. N.

(1966), “Unit-Dose Injectables and the Hospital Medication Error Problem,” Bull. Parent. Drug Assoc. 20: 157.

Carter

J. F. Bolton

(1951), “Reduction of Thrombophlebitis by Limiting the Duration of Intravenous Infusion,” Lancet 2: 20.

Brown

(1970), “Infusion Thrombophlebitis,” Brit. J. Clin. Pract. 24: 197.

Carlin

H. S.

Perkins

A. J.

(1968), “Predicting Pharmaceutical Incompatibilities of Parenteral Medications,” Am. J. Hosp. Pharm. 25: 271.

Colwell

J. A.

Kravitz

Homi

Levin

(1969), “Acidity of Intravenous Dextrose Solutions: A Contributing Factor of Thrombophlebitis?” Hosp. Mgmt. 4: 26.

Donn

(1970), “Intravenous Admixture Incompatibility Information Program”, Bull. Parent. Drug Assoc. 24: 98.

Duma

R. J.

Warner

J. S.

Dalton

H. P.

(1971), “Septicemia from Intravenous Infusions,” New Engl. J. Med. 284: 257.

10.

Dunn

(1970), “IV Incompatibility Information,” Bull. Parent. Drug Assoc. 24: 98.

11.

Eckert

G. M.

Gunner

B. W.

(1970), “Problems with Intravenous Additives,” Aust. Ann. Med. 19: 370.

12.

Editorial (1970), “Penicillin Instability in Infusions,” Brit. Med. J. 4: 571.

13.

Elfving

Saikku

(1966), “Effect of pH on the Incidence of Infusion Thrombophlebitis,” Lancet 1: 953.

14.

Fray

L. O.

(1969), “Control of Air Borne Contamination,” Bull. Parent. Drug Assoc. 23: 80.

15.

Gallelli

J. F.

(1970), “Stability of Antibiotics in Parenteral Solutions,” Am. J. Hosp. Pharm. 27: 528.

16.

Gill

A. W.

Severson

R. W.

N. F.

(1970), “Prediction of Pharmaceutical Stability of Parenteral Solutions II,” Drug Intell. Clin. Pharmacy 4: 243.

17.

N. F.

Goeman

I. A.

(1970), “Prediction of Stability of Parenteral Solutions,” Drug Intell. Clin. Pharmacy 4: 69.

18.

Hockstein

F. A.

(1970), “Stability of Antibiotics in Parenteral Solutions,” Am. J. Hosp. Pharm. 27: 527.

19.

Hoddinott

B. C.

Gowdey

C. W.

Coulton

W. K.

Parker

J. M.

(1967), “Drug Reactions and Errors in Administration in a Medical Ward,” Canad. Med. Assoc. J. 97: 1001.

20.

Holysko

M. N.

Ravin

R. L.

(1965), “A Pharmacy Centralized Intravenous Additive Service,” Am. J. Hosp. Pharm. 22: 266.

21.

Jacobs

(1968), “Survey of Commercial Pharmaceutical Publications,” Practitioner 201: 483.

22.

Jacobs

(1969), “Package Literature and Drug Administration,” Pharm. J. 203: 763.

23.

Jacobs

Superstine

(1970), “Adding Drugs to Intravenous Fluids,” Lancet 2: 1129 (letter).

24.

Jacobs

Nathan

Superstine

Sachs

(1970), “Ampicillin and Carbenicillin in Commonly Used Infusion Solutions,” Drug Intell. Clin. Pharmacy 4: 204.

25.

Johnson

K. T.

Hepler

C. D.

Gallardo

J. P. B.

(1970), “Particulate Contamination in Vials of Dry Sterile Solids,” Am. J. Hosp. Pharm. 27: 968.

26.

Kramer

(1970), “Inspection for Particulate Matter Essential to IV Additive Program,” Drug Intell. Clin. Pharmacy 4: 311.

27.

Kramer

(1970), “Precipitates in Admixtures,” Am. J. Hosp. Pharm. 27: 964.

28.

Kramer

Tanya

J. J.

Harrison

W. L.

(1970), “Precipitates found in Admixtures of Potassium Chloride and Dextrose 5% in Water,” Am. J. Hosp. Pharm. 27: 548.

29.

Latiolais

(1970), “Implications of IV Additive Programs to the Parenteral Industry,” Bull. Parent. Drug Assoc. 24: 45.

30.

Lundgren

Landersjo

(1970), “Studies on the Stability and Compatibility of Drugs in Intravenous Fluids: 1,” Acta Pharm. Suecica, 7: 407.

31.

Lundgren

Landersjo

(1970), “Studies on the Stability and Compatibility of Drugs in Intravenous Fluids: 2,” Acta Pharm. Suecica 7: 509.

32.

Mead

W. B.

(1970), “Precipitates in Admixtures,” Am. J. Hosp. Pharm. 27: 963.

33.

Meyers

E. L.

(1965), “Extemporaneous Mixing of Injectables by Physicians and Pharmacists,” Bull. Parent. Drug. Assoc. 19: 164.

34.

Miller

W. A.

Smith

G. L.

Latiolais

C. J.

(1971), “A Comparative Evaluation of Compounding Costs and Contamination Rates of Intravenous Admixture Systems,” Drug Intell. Clin. Pharmacy 5: 51.

35.

Parker

E. A.

(1970), “Compatibility Digest,” Am. J. Hosp. Pharm. 27: 672.

36.

Parker

E. A.

Boomer

R. J.

Bell

S. C.

(1967), “Parenteral Incompatibilities—Past, Present and Future,” Bull. Parent. Drug Assoc. 21: 197.

37.

Pederson

B. M.

(1970), “A Solution for Post-Infusion Thrombophlebitis,” Am. J. Nursing, 70: 325.

38.

Ravin

R. L.

(1970), “Steps in Starting an Intravenous Program—Equipment and Facilities Required,” Drug Intell. Clin. Pharmacy 4: 97.

39.

Ravin

R. L.

(1970), “Steps in Starting an Intravenous Program—The Reasons to Begin,” Drug Intell. Clin. Pharmacy 4: 13.

40.

Ravin

R. L.

(1970), “Steps in Starting an Intravenous Program—Estimating the Need and Gauging the Usage,” Drug Intell. Clin. Pharmacy 4: 41.

41.

Ritschel

W. A.

(1969), “Therapeutic Incompatibilities between Penicillin and other Antibiotics Administered Intravenously,” Drug Intell. Clin. Pharmacy 3: 355.

42.

Schwartz

M. A.

(1969), “An Analysis of a Hospital IV Additive Service,” Bull. Parent. Drug Assoc. 23: 78.

43.

Shapiro

Slone

Lewis

G. P.

Jick

(1971), “Fatal Drug Reactions Among Medical Inpatients,” J. Amer. Med. Assoc. 216: 467.

44.

Simberkoff

M. S.

Thomas

McGregor

Shenkein

Levine

B. B.

(1970), “Inactivation of Penicillins by Carbohydrate Solutions at Alkaline pH,” New Engl. J. Med. 283: 116.

45.

Song-Ling

(1970), “A Stability Testing Program for Parenteral Products,” Bull. Parent. Drug Assoc. 24: 83.

46.

Stratford

B. C.

(1970), “The Intravenous Use of Gentamicin,” Med. J. Aust. 2: 1267.

47.

Tse

R. L.

Lee

M. W.

(1971), “pH of Infusion Fluids: A Predisposing Factor in Thrombophlebitis,” J. Amer. Med. Assoc. 215: 642.

48.

Wahlgren

(1970), “Contamination Hazards in Multiple Dose Containers for Injections,” Dansk T. Farm. 44: 1.

49.

Weisenfeld

(1968), “Adsorption of Insulin to Intravenous Bottles and Tubing,” Diabetes 17: 766.

50.

Wharton

C. F. P.

(1968), “The Long-Term Administration of Intravenous Antibiotics in Endocarditis,” Am. Heart J. 75: 844.

51.

Wilmore

D. W.

Dudrick

S. J.

(1969), “An In-line Filter for Intravenous Solutions,” Arch. Surg. 99: 462.

52.

Williams

T. W.

Viroslav

Knight

(1970), “Management of Bacterial Endocarditis,” Am. J. Cardiol. 26: 186.

53.

Wuest

J. R.

(1970), “Justifying an IV Additive Program,” Drug Intell. Clin. Pharmacy 4: 125.

54.

Wuest

J. R.

(1970), “Staffing an IV Additive Service,” Drug Intell. Clin. Pharmacy 4: 153.

55.

Wuest

J. R.

(1970), “Initiating an IV Additive Service—Development of Policies and Procedures,” Drug Intell. Clin. Pharmacy 4: 213.

56.

Wuest

J. R.

(1970), “An Intravenous Additive Service—Policies and Procedures,” Drug Intell. Clin. Pharmacy 4: 183.

57.

Wuest

J. R.

(1970), “An Intravenous Additive Service—Equipment and Techniques,” Drug Intell. Clin. Pharmacy 4: 155.